Rayence Co., Ltd. (KOSDAQ:228850)

Market Cap	78.52B -21.0%
Revenue (ttm)	111.39B -15.2%
Net Income	495.35M -95.6%
EPS	31.48 -95.6%
Shares Out	15.74M
PE Ratio	158.52
Forward PE	9.40
Dividend	100.00 (2.00%)
Ex-Dividend Date	Dec 29, 2025

Volume	19,535
Average Volume	23,725
Open	5,120.00
Previous Close	5,060.00
Day's Range	4,900.00 - 5,120.00
52-Week Range	4,835.00 - 7,570.00
Beta	0.57
RSI	43.78
Earnings Date	Feb 13, 2026

About Rayence

Rayence Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and sale of digital X-ray detector products for dental, medical, veterinary, and industrial sectors in South Korea, the United States, Mexico, China, and internationally. The company offers TFT/CMOS X-ray detectors for general radiography, C-arm/RF, mammography, and radiotherapy; and CMOS/Super IGZO TFT/a-Si TFT X-ray detectors for applications, such as dental, veterinary, AXI, die-casting, 2D/3D inline/offline, pipe inspection, etc. It also provides rad...

• Industry: X-Ray Apparatus and Tubes and Related Irradiation Apparatus
• Founded: 2011
• Employees: 221
• Stock Exchange: KOSDAQ
• Ticker Symbol: 228850

Financial Performance

In 2024, Rayence's revenue was 125.56 billion, a decrease of -12.18% compared to the previous year's 142.99 billion. Earnings were 7.83 billion, a decrease of -60.05%.